Delivery Order SPE2DX15D3402-SPE2DX25F1KAB

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $11K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,999.26, is for the delivery of ACTEMRA 162 MG/0.9 ML Syringes. This is a firm fixed-price delivery order contract with a period of performance through January 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.39 firm-fixed-price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, with a completion date of October 25, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $3,798.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Actemra 162 mg/0.9 mL syringes to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,085.48 firm fixed price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, a specialty medication used to treat certain medical conditions. The contract has a completion date of July 26, 2024 and is not set aside for any small business categories. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,368.45, is for the supply of ACTEMRA 162 MG/0.9 ML syringes. This contract is not set aside for any particular business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,194.88 firm fixed-price delivery order is for the supply of ACTEMRA 162 mg/0.9 ml syringes, which are used for various medical treatments. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $9,750.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Actemra 162 mg/0.9 ml syringes to support the government's medical supply needs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,757.04 firm fixed-price delivery order is for the supply of the pharmaceutical product Actemra 162 mg/0.9 ml syringe. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $9,912.96 and is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,795.11 firm fixed price delivery order is for ACTEMRA 162 MG/0.9 ML syringes, with a completion date of October 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DX15D3402
    Indefinite Delivery Contract
  • SPE2DX15D3402-SPE2DX25F1KAB
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,870.66, is for the delivery of 162 mg/0.9 mL Actemra syringes. This is a firm-fixed price delivery order contract with an ultimate completion date of October 16, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The company also has an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable government agencies to efficiently procure essential healthcare materials from Amerisourcebergen.

Generated 1/14/25, 9:03 AM